J0248 HCPCS Level II code: Injection, remdesivir, 1 mg
J0248 is the HCPCS code for “Injection, remdesivir, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0248Injection, remdesivir, 1 mg
Short description: Inj, remdesivir, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0248 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Dec 23, 2021
Where J0248 sits
- 1J codesDrugs administered other than orally
- 2Active code J0248Injection, remdesivir, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0248 mean?
J0248 is the HCPCS code for “Injection, remdesivir, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0248?
CMS lists J0248’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0248
All J codesJ0220Injection, alglucosidase alfa, 10 mg, not otherwise specifiedJ0221Injection, alglucosidase alfa, (lumizyme), 10 mgJ0222Injection, patisiran, 0.1 mgJ0223Injection, givosiran, 0.5 mgJ0224Injection, lumasiran, 0.5 mgJ0225Injection, vutrisiran, 1 mgJ0256Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mgJ0257Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mgJ0270Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)J0275Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)J0278Injection, amikacin sulfate, 100 mgJ0280Injection, aminophyllin, up to 250 mg